Peruvian president Francisco Sagasti said yesterday his interim administration had negotiated vaccine supply deals with Sinopharm Group and AstraZeneca Plc, boosting prospects for a vaccination program that has been slow to take root in the hard-hit Andean nation.
Sagasti said in a televised speech that his government had secured one million vaccine doses from Sinopharm for delivery in January. He said the deal was part of a larger agreement to purchase 38 million doses from the Chinese company.
Sagasti said he had also closed a deal on Wednesday for 14 million doses of the CVOID-19 vaccine developed by AstraZeneca with Oxford University. But that supply is not due to begin arriving in the South American nation until September.